Detailed answers about ENHANCE MEDICAL AESTHETICS CLINIC LIMITED, including incorporation, status, business activity, and accounts information.
When was ENHANCE MEDICAL AESTHETICS CLINIC LIMITED founded?
ENHANCE MEDICAL AESTHETICS CLINIC LIMITED was officially incorporated on 26 September 2018 and is registered under company number 11589111. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ENHANCE MEDICAL AESTHETICS CLINIC LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ENHANCE MEDICAL AESTHETICS CLINIC LIMITED?
ENHANCE MEDICAL AESTHETICS CLINIC LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ENHANCE MEDICAL AESTHETICS CLINIC LIMITED do?
ENHANCE MEDICAL AESTHETICS CLINIC LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is ENHANCE MEDICAL AESTHETICS CLINIC LIMITED's registered address?
The registered office address of ENHANCE MEDICAL AESTHETICS CLINIC LIMITED is THE ANNEXE, MILL HOUSE CORN MILL LANE, TUTBURY, BURTON ON TRENT, DERBYSHIRE, UNITED KINGDOM, DE13 9HA. This is the official address filed with Companies House for legal and statutory correspondence.
Is ENHANCE MEDICAL AESTHETICS CLINIC LIMITED financially stable?
The most recent accounts for ENHANCE MEDICAL AESTHETICS CLINIC LIMITED were made up to 30 September 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 June 2026.